Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.

Thannickal VJ, Henke CA, Horowitz JC, Noble PW, Roman J, Sime PJ, Zhou Y, Wells RG, White ES, Tschumperlin DJ.

Am J Pathol. 2014 Jun;184(6):1643-51. doi: 10.1016/j.ajpath.2014.02.003. Epub 2014 Apr 13. Review.

2.

Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.

Vuga LJ, Milosevic J, Pandit K, Ben-Yehudah A, Chu Y, Richards T, Sciurba J, Myerburg M, Zhang Y, Parwani AV, Gibson KF, Kaminski N.

PLoS One. 2013 Dec 20;8(12):e83120. doi: 10.1371/journal.pone.0083120. eCollection 2013.

3.

Pathogenesis of idiopathic pulmonary fibrosis.

Wolters PJ, Collard HR, Jones KD.

Annu Rev Pathol. 2014;9:157-79. doi: 10.1146/annurev-pathol-012513-104706. Epub 2013 Sep 13. Review.

4.

Mechanistic links between aging and lung fibrosis.

Thannickal VJ.

Biogerontology. 2013 Dec;14(6):609-15. doi: 10.1007/s10522-013-9451-6. Epub 2013 Aug 9. Review.

5.

Fibrotic extracellular matrix activates a profibrotic positive feedback loop.

Parker MW, Rossi D, Peterson M, Smith K, Sikström K, White ES, Connett JE, Henke CA, Larsson O, Bitterman PB.

J Clin Invest. 2014 Apr;124(4):1622-35. doi: 10.1172/JCI71386. Epub 2014 Mar 3.

6.

Global methylation patterns in idiopathic pulmonary fibrosis.

Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N.

PLoS One. 2012;7(4):e33770. doi: 10.1371/journal.pone.0033770. Epub 2012 Apr 10.

7.

Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.

Marinković A, Liu F, Tschumperlin DJ.

Am J Respir Cell Mol Biol. 2013 Apr;48(4):422-30. doi: 10.1165/rcmb.2012-0335OC.

8.

[Expressions of caveolin-1 and extracellular matrix in lung tissues of patients with idiopathic pulmonary fibrosis].

Wang XF, Ding H, Zhou FQ, Meng FQ, Cai HR.

Zhonghua Jie He He Hu Xi Za Zhi. 2012 May;35(5):336-9. Chinese.

PMID:
22883991
9.

Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.

Selman M, Pardo A.

Am J Respir Crit Care Med. 2014 May 15;189(10):1161-72. doi: 10.1164/rccm.201312-2221PP.

PMID:
24641682
10.

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.

Korfei M, Skwarna S, Henneke I, MacKenzie B, Klymenko O, Saito S, Ruppert C, von der Beck D, Mahavadi P, Klepetko W, Bellusci S, Crestani B, Pullamsetti SS, Fink L, Seeger W, Krämer OH, Guenther A.

Thorax. 2015 Nov;70(11):1022-32. doi: 10.1136/thoraxjnl-2014-206411. Epub 2015 Sep 10.

PMID:
26359372
11.

Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.

Nho RS.

Drug Dev Res. 2015 Nov;76(7):343-53. doi: 10.1002/ddr.21272. Epub 2015 Aug 25. Review.

12.

Predisposition for disrepair in the aged lung.

Sueblinvong V, Neujahr DC, Mills ST, Roser-Page S, Ritzenthaler JD, Guidot D, Rojas M, Roman J.

Am J Med Sci. 2012 Jul;344(1):41-51. doi: 10.1097/MAJ.0b013e318234c132.

13.

Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis.

Kliment CR, Oury TD.

Free Radic Biol Med. 2010 Sep 1;49(5):707-17. doi: 10.1016/j.freeradbiomed.2010.04.036. Epub 2010 May 7. Review.

PMID:
20452419
14.

Epigenomics of idiopathic pulmonary fibrosis.

Yang IV.

Epigenomics. 2012 Apr;4(2):195-203. doi: 10.2217/epi.12.10. Review.

15.

Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.

Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, Shin EK, Jung S, Jang AS, Park SW, Uh ST, Kim YH, Park JS, Sin HG, Youm W, Koh ES, Cho SY, Paik YK, Rhim TY, Park CS.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):633-42. doi: 10.1164/rccm.200905-0659OC. Epub 2010 May 12.

PMID:
20463180
16.
17.

Metalloproteinases in idiopathic pulmonary fibrosis.

Dancer RC, Wood AM, Thickett DR.

Eur Respir J. 2011 Dec;38(6):1461-7. doi: 10.1183/09031936.00024711. Epub 2011 Jun 23. Review.

18.

Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.

Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M, Zhao D, Chen Y, Liu S, Dong Y, Li X, Lu Y, Yang B, Shan H.

Cell Death Dis. 2014 May 22;5:e1238. doi: 10.1038/cddis.2014.207.

19.

The role of miR-29 in pulmonary fibrosis.

Cushing L, Kuang P, Lü J.

Biochem Cell Biol. 2015 Apr;93(2):109-18. doi: 10.1139/bcb-2014-0095. Epub 2014 Sep 18. Review.

PMID:
25454218
20.

MicroRNAs in idiopathic pulmonary fibrosis.

Pandit KV, Milosevic J, Kaminski N.

Transl Res. 2011 Apr;157(4):191-9. doi: 10.1016/j.trsl.2011.01.012. Epub 2011 Feb 4. Review.

PMID:
21420029

Supplemental Content

Support Center